Literature DB >> 8173929

Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy.

T Holm1, B Cedermark, L E Rutqvist.   

Abstract

The natural history of locally recurrent rectal cancer was analysed to assess whether preoperative irradiation altered the clinical course of the disease. In a randomized controlled trial of 849 patients, the value of preoperative radiotherapy in those with operable rectal adenocarcinoma was examined. After a minimum follow-up of 4 years, 156 patients who developed local recurrence were studied retrospectively. There were no differences concerning symptoms and the site of local recurrence between irradiated and non-irradiated patients. Curative treatment was rarely possible and median survival was only about 1 year, irrespective of adjuvant treatment. Local recurrence was the only manifestation of disease in 30-50 per cent of patients. An earlier and more aggressive surgical approach might improve survival.

Entities:  

Mesh:

Year:  1994        PMID: 8173929     DOI: 10.1002/bjs.1800810344

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

1.  Pre-operative radiochemotherapy of locally advanced rectal cancer.

Authors:  Xiao-Nan Sun; Qi-Chu Yang; Jian-Bin Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

3.  Survival after rectal cancer: differences between hospital catchment areas. A nationwide study in Sweden.

Authors:  P Blomqvist; A Ekbom; O Nyrén; U B Krusemo; R Bergström; H O Adami
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 4.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

5.  Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Authors:  Chie Takasu; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Masanori Nishioka; Shinya Morimoto; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Tohru Utsunomiya; Hisanori Uehara
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

6.  Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience.

Authors:  Seung Yeop Oh; Young Bae Kim; Ok Joo Paek; Kwang Wook Suh
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

7.  Ezrin expression in rectal cancer predicts time to development of local recurrence.

Authors:  Fredrik Jörgren; Mef Nilbert; Eva Rambech; Pär-Ola Bendahl; Gudrun Lindmark
Journal:  Int J Colorectal Dis       Date:  2012-01-12       Impact factor: 2.571

8.  Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma.

Authors:  E C Poulin; C M Schlachta; R Grégoire; P Seshadri; M O Cadeddu; J Mamazza
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

9.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies.

Authors:  Jun Gon Kim; Kyoung Doo Song; Dong Ik Cha; Hee Cheol Kim; Jeong Il Yu
Journal:  Int J Colorectal Dis       Date:  2018-07-13       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.